A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial, which included adult patients with no upper…
Continue Reading
News Source: medicalxpress.com
Leave a Reply